← All stocks

ARVINAS, INC.

ARVN Net selling

CIK 0001655759 #2976 in the set updated 19 Sep 2026

Bought (12 mo)

$495.08K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.42M

$66.04K on a plan · $0.00 straight out of an exercise

Sold at will

$1.36M

21 of 23 sales

Net

−$926.08K

−$860.04K against sales at will

By person

15 insiders · 25 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Morrison Briggs

Director

$495.08K (2)

—

+$495.08K

111,548

0.1706%

$910.12K

+271.9%

Houston John G

Director

—

$466.15K (3)

−$466.15K

1,122,183

1.72%

$9.16M

+8.2%

Berkowitz Noah

Chief Medical Officer

—

$249.41K (3)

−$249.41K

191,395

0.2927%

$1.56M

+201.6%

Teel Randy

President and CEO

—

$226.48K (5)

−$226.48K

285,009

0.4359%

$2.33M

+80.1%

Saik Andrew

Chief Financial Officer

—

$218.21K (3)

−$218.21K

187,432

0.2867%

$1.53M

+205.2%

Cacace Angela M

Chief Scientific Officer

—

$214.01K (5)

−$214.01K

180,390

0.2759%

$1.47M

+234.5%

Loomis David K

VP, Chief Accounting Officer

—

$46.90K (4)

−$46.90K

40,193

0.0615%

$327.93K

+262.7%

Taylor Ian

President, R&D

—

159,121

0.2434%

$1.30M

+7.9%

Kennedy Edward Moore Jr.

Director

—

54,957

0.0840%

$448.39K

+134.8%

Norwalk Leslie V

Director

—

41,572

0.0636%

$339.19K

+314.9%

Cunningham Everett

Director

—

41,572

0.0636%

$339.19K

+314.9%

Smaldone Alsup Laurie

Director

—

41,572

0.0636%

$339.19K

+314.9%

Bain Linda

Director

—

41,572

0.0636%

$339.19K

+314.9%

AGARWAL SUNIL

Director

—

30,166

0.0461%

$246.12K

+113.3%

YOUNG JOHN D

Director

—

26,045

0.0398%

$212.50K

+159.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Morrison Briggs

6 Mar 2026

Director

Buy

20,000

$13.40

$268.07K

Morrison Briggs

22 Sep 2025

Director

Buy

30,000

$7.57

$227.01K

Show all 25 transactions →

What was left out

Form 4 filings counted 32

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 0

Sales at will 21

Transactions with no price 0

Shares from compensation/vesting 388,373

History held since 28 Sep 2018